Home > Healthcare > Medical Devices > Diagnostic Devices > IVD in Cardiology and Neurology Market

IVD in Cardiology and Neurology Market Share

Report ID: GMI8846
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

IVD in Cardiology and Neurology Market Share

The IVD in cardiology and neurology industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

IVD in Cardiology and Neurology Market Companies

Some of the eminent market participants operating in the IVD in cardiology and neurology industry include:

Abbott Laboratories
Becton, Dickinson and Company
bioMerieux S.A.
Bio-Rad Laboratories, Inc.
Danaher Corporation
DiaSorin S.p.A.
F. Hoffmann-La Roche Ltd.
QIAGEN N.V.
Siemens Healthineers AG
Sysmex Corporation
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

IVD in cardiology and neurology industry size was USD 15.6 billion in 2023 and is estimated to exceed USD 24 billion by 2032, due to increasing incidence and prevalence of cardiovascular diseases (CVDs) and neurological disorders like Alzheimer's disease, Parkinson's disease, and stroke.

The reagents, kits, & consumables product type segment is estimated to record USD 12 billion by the end of 2032, owing to higher adoption in diagnostic testing for cardiovascular and neurological disorders.

North America held 40.8% of the IVD in cardiology and neurology industry share in 2023, and will witness significant growth till 2032, due to presence of well-established healthcare infrastructure, advanced diagnostic technologies, and a strong emphasis on R&D in the field of medicine.

Abbott Laboratories, Becton, Dickinson, and Company, bioMerieux S.A., Bio-Rad Laboratories, Inc., Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., QIAGEN N.V., Siemens Healthineers AG, Sysmex Corporation, and Thermo Fisher Scientific Inc.